Table 1. Correlation between clinicopathological features and the GOPLH3, p-mTOR expression in gastric cancer specimen.
Clinicopathologicalvariable | Number | GOLPH3 expression | p-mTOR expression | ||||
High | Low | p value | High | Low | p value | ||
Age (years) | 0.801 | 0.700 | |||||
≥55 | 46 | 27 | 19 | 25 | 21 | ||
<55 | 34 | 19 | 15 | 17 | 17 | ||
Gender | 0.833 | 0.917 | |||||
Male | 51 | 34 | 17 | 27 | 24 | ||
Female | 29 | 20 | 9 | 15 | 14 | ||
Histological grade | 0.011* | 0.030* | |||||
Well/moderate | 36 | 20 | 16 | 15 | 21 | ||
Poorly | 44 | 36 | 8 | 29 | 15 | ||
Depth of invasion | 0.007* | 0.001* | |||||
T1/T2 | 39 | 17 | 22 | 23 | 26 | ||
T3/T4 | 41 | 30 | 11 | 33 | 8 | ||
Lymph node metastasis | 0.004* | 0.015* | |||||
NO | 38 | 8 | 30 | 16 | 22 | ||
YES | 42 | 31 | 11 | 29 | 13 | ||
Distant metastasis | 0.002* | 0.022* | |||||
NO | 53 | 20 | 33 | 23 | 30 | ||
YES | 27 | 20 | 7 | 19 | 8 |
The associations between protein expression and clinicopathological variables were estimated using the chi-squared test.
*Significant at the level of p<0.05.